about
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.Cellular immune reconstitution after haploidentical transplantation in children.Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo.Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia.NK cytotoxicity and alloreactivity against neuroblastoma cell lines in vitro: comparison of Europium fluorometry assay and quantification by RT-PCR.Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice.High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia.Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies.Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children.Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children.Long-term outcome after haploidentical stem cell transplantation in children.Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy.Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients.Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses.Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors.Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitroDetermination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separationsAdenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an updateImmunological aspects of haploidentical stem cell transplantation in childrenChimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allograftsClinical scale isolation of T cell-depleted CD56+ donor lymphocytes in childrenHaploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effectsFlow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantationEffective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16)Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion proteinRituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantationCytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clonesSiglec-7 tetramers characterize B-cell subpopulations and leukemic blastsIL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCTImmune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted graftsExtracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHDDepletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device
P50
Q33828575-FFBD4A45-9279-45CE-A42F-9D3B06A5B6E4Q36795165-D945BE34-6473-4043-8FF6-7779B2B19B00Q37045924-EAED6D2E-0544-49C8-8296-299F8F84C3F6Q38925395-9AA76271-F4CA-47ED-8797-7BC3968D2BAFQ39156647-DC68286D-F5F2-4BFC-AFB5-1E56F0BAB9BFQ39362110-E3AC642C-DBA1-409E-878B-288D5C0D8C39Q39660631-1D051ACE-5BC9-4750-9D2D-DBAE30420854Q39795948-42B3C65A-C5C8-4866-A04E-E1B2B6D4FF3CQ40122695-4195A5F3-5F72-47BA-94B2-81A3846D4C03Q40174651-2BE1C7B2-2557-4F18-A97A-C14EF67EF4F8Q40285437-D211CEEE-6BFB-4FA5-AF5E-A7D3F7D4BF51Q40305996-FFC1F678-7631-47CF-B7E5-748FECCE0436Q40311800-0F55A47B-5BC3-4BB4-A1DE-DB6EAC78EE7EQ41808643-000BD10C-941F-4D17-86EE-501345E33795Q43775700-D94E5920-EDB6-468D-9865-3E4AF9A843CDQ45075588-6B597064-68D5-42CF-A9B2-7A7798C2105EQ45877060-64B10868-F0DE-4C02-8375-ED09B555C525Q46367081-B9556340-884E-46B6-8082-26E1B7760E9AQ46924115-C025F751-C3E9-42F8-A64D-8964365BE9DEQ46989629-F3DBD8F9-D2E1-416A-8881-2657C9F2B4CFQ51315475-0D62DA10-A935-434F-8597-EE25C9DE5261Q57257167-DDA27E4D-4C67-486F-9793-6B8F86619401Q57373236-654D3CEF-55E8-46F4-AAB1-6A457A2313C1Q64378254-C8D0AC54-C3C3-4CEB-908C-86506046668DQ74218191-16616A9C-2193-43EF-8CEE-8B78088041D5Q75424215-B4232C2A-AEBB-4A58-89D4-D216562468E7Q77961981-5723C16D-12D5-494A-B185-CB598F1CD5FEQ79323806-59D2EC1F-8356-4B86-8A97-098C2F018F6BQ80168024-E6378C8F-C73E-40F0-94D9-512A4D79CD75Q80393059-1CC8D5E4-C72D-4E87-A354-67E8C9621854Q80706475-36802AB3-C540-4859-9A28-AAE34B366DFCQ81772371-44739F31-D4E9-4FC8-B7B2-E6F8BF3DBF7CQ83200710-6124AE12-1A76-4EF2-9680-D99696251DD4Q84129754-3B8F2924-7E7C-4B1C-9E19-AC8080FE7B86Q84589982-FE860858-21E1-45D6-96B6-5128FEBF00DCQ85190974-D25A179F-E612-43DF-8FAB-B904B8173006Q87165745-2662CB76-A783-4930-8C68-51488DEE0379Q87339052-BB61D3B1-DCE1-45E8-A605-CC39D7DDC0C2
P50
description
German pediatrician
@en
deutscher Kinderarzt
@de
kinderarts
@nl
name
Matthias Pfeiffer
@ast
Matthias Pfeiffer
@de
Matthias Pfeiffer
@en
Matthias Pfeiffer
@es
Matthias Pfeiffer
@nl
Matthias Pfeiffer
@sl
type
label
Matthias Pfeiffer
@ast
Matthias Pfeiffer
@de
Matthias Pfeiffer
@en
Matthias Pfeiffer
@es
Matthias Pfeiffer
@nl
Matthias Pfeiffer
@sl
altLabel
Matthias M. Pfeiffer
@de
Matthias M. Pfeiffer
@en
Matthias Manuel Pfeiffer
@de
Matthias Manuel Pfeiffer
@en
prefLabel
Matthias Pfeiffer
@ast
Matthias Pfeiffer
@de
Matthias Pfeiffer
@en
Matthias Pfeiffer
@es
Matthias Pfeiffer
@nl
Matthias Pfeiffer
@sl
P214
P227
P106
P21
P214
P227
P31
P496
0000-0003-2607-5556
P569
1975-01-01T00:00:00Z
P735
P7859
viaf-1085885